RCSB PDB - 3KQ0: Crystal structure of human alpha1-acid glycoprotein
Distribution and plasma protein binding | Cambridge MedChem Consulting
An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action | Scientific Reports
Biomedicines | Free Full-Text | α1-Acid Glycoprotein-Decorated Hyaluronic Acid Nanoparticles for Suppressing Metastasis and Overcoming Drug Resistance Breast Cancer
Understanding the interaction between α-1-acid glycoprotein (AGP) and potential Cu/Zn metallo-drugs of benzimidazole derived organic motifs: A multi-spectroscopic and molecular docking study - ScienceDirect
Figure 2 from The 1.8-A crystal structure of alpha1-acid glycoprotein (Orosomucoid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin. | Semantic Scholar
Plasma concentrations of alpha-1-acid glycoprotein in preterm and term newborns: influence of mode of delivery and implications for plasma protein binding of local anaesthetics - British Journal of Anaesthesia
Plasma concentrations of alpha-1-acid glycoprotein in preterm and term newborns: influence of mode of delivery and implications for plasma protein binding of local anaesthetics - British Journal of Anaesthesia
Human alpha 1-Acid Glycoprotein Antibody MAB3694: R&D Systems
Acute phase α1-acid glycoprotein as a siderophore-capturing component of the human plasma: A molecular modeling study - ScienceDirect
alpha 1-Acid Glycoprotein Antibody (386131) [Unconjugated] (MAB3694): Novus Biologicals
Molecular Characterization of Lipopolysaccharide Binding to Human α-1-Acid Glycoprotein
a1-Acid Glycoprotein = 99 66455-27-4
Fucosylated α1-acid glycoprotein as a biomarker to predict prognosis following tumor immunotherapy of patients with lung cancer | Scientific Reports